Provided by Tiger Trade Technology Pte. Ltd.

Surrozen, Inc.

29.32
-0.6800-2.27%
Post-market: 29.320.00000.00%19:48 EDT
Volume:646.04K
Turnover:19.11M
Market Cap:344.62M
PE:-0.91
High:30.68
Open:30.57
Low:28.93
Close:30.00
52wk High:37.83
52wk Low:11.39
Shares:11.75M
Float Shares:4.62M
Volume Ratio:0.65
T/O Rate:13.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-32.1892
EPS(LYR):-32.3700
ROE:-62.80%
ROA:-25.39%
PB:-1.58
PE(LYR):-0.91

Loading ...

Surrozen to Advance Potential Eye Drug into Clinical Development Following FDA Clearance

MT Newswires Live
·
Yesterday

Surrozen announces FDA clearance of IND application for SZN-8141

TIPRANKS
·
Yesterday

Surrozen Says FDA Clears IND for SZN-8141 Diabetic Macular Edema Trial

Reuters
·
Yesterday

Surrozen, - FDA Clearance Triggers Second Closing of Private Placement for $95.10 Mln

THOMSON REUTERS
·
Yesterday

Surrozen, - First Patient Dosing in DUET Study Expected in Q4 2026

THOMSON REUTERS
·
Yesterday

Surrozen Announces FDA Clearance of Ind Application for Szn-8141 for the Treatment of Diabetic Macular Edema

THOMSON REUTERS
·
Yesterday

Surrozen price target raised to $54 from $44 at H.C. Wainwright

TIPRANKS
·
Sep 25

US Stocks on the MOVE-Charles River, Oracle, TD Synnex

Reuters
·
Sep 24

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surrozen (SRZN), Liquidia Technologies (LQDA) and Universal Health (UHS)

TIPRANKS
·
Sep 09

Surrozen submits investigational new drug application for SZN-8141

TIPRANKS
·
Sep 08

Surrozen Submits FDA IND for SZN-8141 in Diabetic Macular Edema

Reuters
·
Sep 08

Surrozen, - to Initiate DUET Phase 1B/2a Study by Year-End 2026, Initial Data in H2 2027

THOMSON REUTERS
·
Sep 08

Surrozen Announces Submission of Ind Application for Szn-8141 for the Treatment of Diabetic Macular Edema

THOMSON REUTERS
·
Sep 08

Surrozen Initiated at Outperform by William Blair

Dow Jones
·
Aug 21

William Blair Initiates Surrozen at Outperform

MT Newswires Live
·
Aug 20

Guggenheim Keeps Their Buy Rating on Surrozen (SRZN)

TIPRANKS
·
Aug 14

Guggenheim Keeps Their Buy Rating on Surrozen (SRZN)

TIPRANKS
·
Aug 10

Surrozen Price Target Maintained with a $44.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 10

Surrozen, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 08

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 07